Significance of highly fermentable dietary fiber in enteral nutrition patients

Yamamoto Takeshi0 个研究点目标入组 40 人开始时间: 2023年12月22日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1) In principle, over 65 years old and under 90 years old.
•Because we wanted to evaluate the effect on elderly people, we selected patients aged 65 and older. Also, the reason why it was chosen to be under 90 years old
•This was because it was determined that people over 90 years of age are not eligible for research because it has been shown that there are many metabolites that are associated with the risk of age-related diseases and weaken the intestinal barrier function.
•However, if there are not enough research participants, those who wish to participate will be eligible to participate in the research if they are 60 years of age or older.
•2) Gender doesn't matter.
•3) Patients who are administering enteral nutritional products into the stomach through the nasal passage or gastrostomy.
•4) Patients who are hospitalized during the study period.
•5) Free consent from the person who has the capacity to consent, or from a representative consenter when the person lacks the capacity to consent.
•Patients who can provide written informed consent.

•1) Patients who do not have permission from their attending physician.
•2) Patients with a history of hypersensitivity to dietary fiber.
•3) Patients with milk protein allergy.
•4) Patients with no residual gastric or intestinal function.
•5) Patients with ileus.
•6) Patients with severe liver/kidney disorder. (e.g. acute and chronic renal failure, liver cirrhosis, etc.)
•7) Patients with glucose metabolism abnormalities such as severe diabetes.
•8) Patients with congenital amino acid metabolism abnormalities.
•9) Patients with a history of esophagus or stomach resection (minimally invasive surgery such as endoscopic submucosal dissection is excluded)
•10) Patients who have had a history of intestinal resection within one year before consent was obtained (excluding minor cases such as removal of polyps or appendix).
•11) Patients who have difficulty collecting the amount of blood necessary for testing.
•12) Patients who had a fever of 37.5temperature or higher within 3 days of the start of the study.

发起方

Yamamoto Takeshi